From the Department of Cardiovascular Medicine, Graduate School of Medical Sciences (R.U., J.K., T.M., S.K., H.T.), Kyushu University, Fukuoka, Japan.
the Department of Cardiovascular Research, Development, and Translational Medicine, Center for Cardiovascular Disruptive Innovation (J.K., K.E.), Kyushu University, Fukuoka, Japan.
Arterioscler Thromb Vasc Biol. 2020 Jul;40(7):e214-e226. doi: 10.1161/ATVBAHA.120.314383. Epub 2020 Jun 4.
Mitochondria consistently change their morphology in a process regulated by proteins, including Drp1 (dynamin-related protein 1), a protein promoting mitochondrial fission. Drp1 is involved in the mechanisms underlying various cardiovascular diseases, such as myocardial ischemia/reperfusion injury, heart failure, and pulmonary arterial hypertension. However, its role in macrophages, which promote various vascular diseases, is poorly understood. We therefore tested our hypothesis that macrophage Drp1 promotes vascular remodeling after injury.
To explore the selective role of macrophage Drp1, we created macrophage-selective Drp1-deficient mice and performed femoral arterial wire injury. In these mice, intimal thickening and negative remodeling were attenuated at 4 weeks after injury when compared with control mice. Deletion of macrophage Drp1 also attenuated the macrophage accumulation and cell proliferation in the injured arteries. Gain- and loss-of-function experiments using cultured macrophages indicated that Drp1 induces the expression of molecules associated with inflammatory macrophages. Morphologically, mitochondrial fission was induced in inflammatory macrophages, whereas mitochondrial fusion was induced in less inflammatory/reparative macrophages. Pharmacological inhibition or knockdown of Drp1 decreased the mitochondrial reactive oxygen species and chemotactic activity in cultured macrophages. Co-culture experiments of macrophages with vascular smooth muscle cells indicated that deletion of macrophage Drp1 suppresses growth and migration of vascular smooth muscle cells induced by macrophage-derived soluble factors.
Macrophage Drp1 accelerates intimal thickening after vascular injury by promoting macrophage-mediated inflammation. Macrophage Drp1 may be a potential therapeutic target of vascular diseases.
线粒体的形态不断变化,这一过程受到包括 Drp1(与动力蛋白相关的蛋白 1)在内的蛋白质的调节,Drp1 是一种促进线粒体裂变的蛋白质。Drp1 参与多种心血管疾病的发病机制,如心肌缺血/再灌注损伤、心力衰竭和肺动脉高压。然而,其在促进多种血管疾病的巨噬细胞中的作用尚未被充分了解。因此,我们验证了这样一个假设,即巨噬细胞 Drp1 促进损伤后的血管重塑。
为了探究巨噬细胞 Drp1 的选择性作用,我们构建了巨噬细胞特异性 Drp1 缺失小鼠,并进行了股动脉线损伤实验。与对照组小鼠相比,这些小鼠在损伤后 4 周时,内膜增厚和负性重塑减轻。巨噬细胞 Drp1 的缺失也减轻了损伤动脉中的巨噬细胞积累和细胞增殖。利用培养的巨噬细胞进行的增益和失活实验表明,Drp1 诱导与炎症巨噬细胞相关的分子表达。形态上,在炎症性巨噬细胞中诱导线粒体裂变,而在炎症反应较低/修复性巨噬细胞中诱导线粒体融合。在培养的巨噬细胞中,Drp1 的药理学抑制或敲低降低了线粒体活性氧和趋化活性。巨噬细胞与血管平滑肌细胞的共培养实验表明,巨噬细胞 Drp1 的缺失抑制了由巨噬细胞衍生的可溶性因子诱导的血管平滑肌细胞的生长和迁移。
巨噬细胞 Drp1 通过促进巨噬细胞介导的炎症加速血管损伤后的内膜增厚。巨噬细胞 Drp1 可能是血管疾病的潜在治疗靶点。